Tigecycline: A Broad-Spectrum Antibiotic for Treating Bacterial Infections
Tigecycline is a broad-spectrum antibiotic that has been used to treat a wide range of bacterial infections. Developed by Wyeth Pharmaceuticals (now a part of Pfizer), tigecycline was approved by the US FDA in 2005 for the treatment of complicated skin and skin structure infections (cSSSI) and community-acquired bacterial pneumonia (CABP).
What is Tigecycline?
Tigecycline is a glycylcycline antibiotic, a class of antibiotics that are derived from the tetracycline family. It works by inhibiting protein synthesis in bacteria, ultimately leading to the death of the bacterial cells. Tigecycline has a broad spectrum of activity, meaning it can target a wide range of bacteria, including both Gram-positive and Gram-negative bacteria.
Indications for Tigecycline
Tigecycline is indicated for the treatment of the following bacterial infections:
* Complicated Skin and Skin Structure Infections (cSSSI): Tigecycline is effective against a wide range of bacteria that cause cSSSI, including Staphylococcus aureus, Streptococcus pyogenes, and Enterococcus faecalis.
* Community-Acquired Bacterial Pneumonia (CABP): Tigecycline is also effective against a wide range of bacteria that cause CABP, including Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
* Abdominal Infections: Tigecycline has also been used to treat abdominal infections, including peritonitis and intra-abdominal infections caused by bacteria such as Escherichia coli and Klebsiella pneumoniae.
* Bacteremia: Tigecycline has been used to treat bacteremia, a condition in which bacteria are present in the bloodstream.
Mechanism of Action
Tigecycline works by binding to the 30S subunit of the bacterial ribosome, which is responsible for protein synthesis. This binding inhibits the initiation of protein synthesis, ultimately leading to the death of the bacterial cells.
Resistance to Tigecycline
Resistance to tigecycline is a growing concern. According to a study published in the Journal of Antimicrobial Chemotherapy, resistance to tigecycline has been reported in several countries, including the United States, Europe, and Asia. Resistance to tigecycline can be caused by mutations in the bacterial ribosome or by the production of enzymes that inactivate the antibiotic.
Side Effects of Tigecycline
Tigecycline can cause a range of side effects, including nausea, vomiting, diarrhea, and abdominal pain. In rare cases, tigecycline can cause more serious side effects, including liver damage and allergic reactions.
Conclusion
Tigecycline is a broad-spectrum antibiotic that has been used to treat a wide range of bacterial infections. While it has a broad spectrum of activity, resistance to tigecycline is a growing concern. As with any antibiotic, tigecycline should be used judiciously and only when necessary.
Key Takeaways
* Tigecycline is a broad-spectrum antibiotic that has been used to treat a wide range of bacterial infections.
* Tigecycline is effective against a wide range of bacteria, including both Gram-positive and Gram-negative bacteria.
* Resistance to tigecycline is a growing concern.
* Tigecycline can cause a range of side effects, including nausea, vomiting, diarrhea, and abdominal pain.
Frequently Asked Questions
1. What is tigecycline used to treat?
Tigecycline is used to treat a wide range of bacterial infections, including complicated skin and skin structure infections, community-acquired bacterial pneumonia, abdominal infections, and bacteremia.
2. How does tigecycline work?
Tigecycline works by inhibiting protein synthesis in bacteria, ultimately leading to the death of the bacterial cells.
3. What are the side effects of tigecycline?
Tigecycline can cause a range of side effects, including nausea, vomiting, diarrhea, and abdominal pain.
4. Is tigecycline effective against all types of bacteria?
No, tigecycline is not effective against all types of bacteria. Resistance to tigecycline is a growing concern.
5. Can tigecycline be used in pregnant or breastfeeding women?
Tigecycline should be used with caution in pregnant or breastfeeding women, as it can cause harm to the fetus or baby.
Sources
1. DrugPatentWatch.com: Tigecycline (Tygacil) - Drug Patent Information. Retrieved from <https://www.drugpatentwatch.com/drug/tigecycline-tygacil>
2. Journal of Antimicrobial Chemotherapy: Resistance to tigecycline in Gram-negative bacteria. (2013). Journal of Antimicrobial Chemotherapy, 68(10), 2315-2323.
3. Wyeth Pharmaceuticals: Tigecycline (Tygacil) - Prescribing Information. Retrieved from <https://www.wyeth.com/products/tigecyclineprescribinginformation.pdf>
4. Pfizer: Tigecycline (Tygacil) - Product Information. Retrieved from <https://www.pfizer.com/products/product-detail/tigecycline-tygacil>
5. MedlinePlus: Tigecycline - MedlinePlus. Retrieved from <https://medlineplus.gov/druginfo/meds/a607030.html>